NCT03328299View on ClinicalTrials.gov

Pharmacokinetics and Dynamics of Dexmedetomidine as Adjuvant in TAP Block

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 11, 2017

Primary Completion Date

December 1, 2018

Study Completion Date

September 1, 2019

Conditions
Postoperative Pain
Interventions
DRUG

Dexmedetomidine

20 ml of 0.5 % bupivacaine plus dexmedetomidine 1 μg•kg-1

DRUG

bupivacaine

20 ml of 0.5 % bupivacaine

Trial Locations (1)

171516

South Egypt Cancer instIitute, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03328299 - Pharmacokinetics and Dynamics of Dexmedetomidine as Adjuvant in TAP Block | Biotech Hunter | Biotech Hunter